Charity Huang, MD
Dr. Charity Huang is a dedicated physician with an unwavering commitment to providing high-quality oncological care to underserved communities. She is a staunch advocate for accessible healthcare and actively volunteers with Binaytara Foundation to make a positive impact in the community. In additional to her clinical practice, Dr. Huang serves as a mentor for teaching fellows at Harbor UCLA Medical Center, where she imparts her knowledge and passion for medicine to the next generation of healthcare providers. She is championing the initiative to open clinical trials to underserved patients in Los Angeles County, recognizing the critical importance of ensuring equitable access to cutting-edge medical interventions for this diverse and populous region. By breaking down barriers and expanding eligibility criteria, Dr. Huang's efforts are aimed at addressing healthcare disparities and offering potentially life-saving treatments to those who have historically been underrepresented in medical research in this densely populated county.
Financial relationships
-
Attribution:SelfType of financial relationship:OtherIneligible company:Roche/GenentechDate added:09/07/2023Date updated:09/07/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:PfizerDate added:09/07/2023Date updated:09/07/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:RegeneronDate added:09/07/2023Date updated:09/07/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:AmgenDate added:09/07/2023Date updated:09/07/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:Eli LillyDate added:09/07/2023Date updated:09/07/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:SeagenDate added:09/07/2023Date updated:09/07/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:NateraDate added:09/07/2023Date updated:09/07/2023
-
Attribution:SelfType of financial relationship:OtherIneligible company:Theradex OncologyDate added:09/07/2023Date updated:09/07/2023